Search
Close this search box.
Search
Close this search box.

June 30, 2026

New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome

Advanced analytical methods integrating clinical trial and real-world data address key evidence gaps in rare, difficult-to-treat blood cancers Across both studies, mogamulizumab was associated with improved survival outcomes compared to standard of care PRINCETON, N.J., June 30, 2026 (GLOBE NEWSWIRE) — Researchers at the World Congress of Cutaneous Lymphoma 2026

New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome

Advanced analytical methods integrating clinical trial and real-world data address key evidence gaps in rare, difficult-to-treat blood cancers Across both studies, mogamulizumab was associated with improved survival outcomes compared to standard of care PRINCETON, N.J., June 30, 2026 (GLOBE NEWSWIRE) — Researchers at the World Congress of Cutaneous Lymphoma 2026

CGTN: From the people, for the people: What the July 1 Medal honors

BEIJING, June 30, 2026 (GLOBE NEWSWIRE) — CGTN has published an article exploring the values embodied by the July 1 Medal. Through the stories of this year’s recommended nominees, the article highlights how generations of the Communist Party of China (CPC) members have remained rooted among the people, dedicated themselves